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On the cell surface, TGF-β superfamily growth factors, including TGF-βs, activins, and bone morphogenetic proteins (BMPs), bind to type I and type II serine/threonine kinase receptors. Upon association with the ligand, type II receptors form a complex with their respective type I receptors. Subsequently, TGF-β and activin signals progress through phosphorylation of receptor-activated Smads (R-Smads) 2 and 3, whereas R-Smads 1, 5, and 8 mediate BMP signaling. R-Smads of both pathways eventually heteroligomerize with the common mediator Smad4, and the resulting complex translocates to the nucleus and recruits transcriptional cofactors to control gene expression. Additionally, in a negative feedback mechanism, Smad6 and 7 inhibit TGF-β superfamily signaling by competing with R-Smads for Smad4 interaction and receptor binding and by targeting receptors for ubiquitination and degradation. In addition to the canonical Smad circuitry, TGF-β superfamily members have been reported to signal through other pathways, predominantly including members of the mitogen-activated protein kinase (MAPK) family (1) .
In the hematopoietic system, numerous TGF-β family members have been established as modulators of hematopoietic stem cell (HSC) fate decisions (2) (3) (4) . BMP-4 is critical for mesoderm formation and, thus, hematopoietic development in various model organisms, as well as from human embryonic stem cells. Furthermore, BMP stimulation aff ects proliferation and diff erentiation of human hematopoietic progenitors and can prolong the maintenance of functional human cord blood HSCs in vitro through as of yet unidentifi ed mechanisms. Conversely, the TGF-βs are generally context-dependent, potent inhibitors of primitive hematopoietic cell proliferation in vitro. The mechanisms behind TGF-β-induced growth arrest in hematopoietic progenitors are intricate, involving both downregulation of cytokine receptors and modulation of genes involved in the cell cycle. Previously, it has been reported that TGF-β1-null mice and inducible TGF-β receptor (TβR) knockout models develop a transplantable lethal infl ammatory disorder aff ecting multiple organs (5-7).
However, transplantation experiments using BM from TβRI −/− mice failed to reveal any eff ect on HSC proliferation and diff erentiation in vivo, even though TβRI-defi cient primitive hematopoietic cells had increased proliferative capacity in vitro under low stimulatory conditions (8) . Redundant mechanisms within the Smad signaling network or cross talk with other pathways relevant in the more complex and enduring in vivo setting may account for this discrepancy between in vitro and in vivo fi ndings. Indeed, members of the Wnt-, Notch-, and MAPK-signaling pathways have been suggested to interact with the Smads in other contexts (9) (10) (11) . Recent work identifi es the nuclear protein transcription intermediary factor 1 (TIF1) γ as a competitor to Smad4 for R-Smad binding in human CD34 + cells, demonstrating additional complexities in the interaction between the canonical Smad pathway and other regulatory circuits in hematopoietic cells (12) .
In this paper, we have studied the complete role of Smad4-dependent signaling in HSCs and hematopoiesis by means of inducible MxCre/Smad4 −/− mice. Previously, several groups demonstrated that conventional Smad4 −/− embryos die at embryonic day 7.5 because of an impaired proliferation of the ectoderm, resulting in a lack of mesoderm formation (13, 14) . Adult Smad4 heterozygote mice develop polyps and tumors of the gastrointestinal tract (15, 16) , fi ndings that have also been observed in human patients with juvenile polyposis syndrome caused by SMAD4 mutations (17) . Correspondingly, we observed that MxCre-induced deletion of Smad4 in hematopoietic and extrahematopoietic tissues results in histopathological changes in the colonic mucosa and intestinal bleeding, reinforcing the importance of Smad signaling in colon homeostasis. By using cells from these mice in BM transplantation settings, we have isolated 
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hematopoietic-intrinsic and extrahematopoietic defects associated with Smad4 defi ciency. Importantly, we reveal a novel role for Smad4-dependent signaling as a cell-autonomous critical regulator of HSC self-renewal in vivo.
RESULTS AND D I S C U S S I O N Induced Smad4 deletion is lethal in a manner distinct from the infl ammatory phenotype of upstream TGFsignaling knockouts In addition to the MxCre-induced gene deletion being essentially 100% effi cient in the BM, the Mx1 promoter is active in numerous other tissues (18) . Hence, we created two experimental models: one in which steady-state WT or transgenic MxCre/Smad4 fl /fl were induced (hereafter referred to as Smad4 −/− or Smad4 defi cient), and another in which lethally irradiated Smad4 fl /fl mice were transplanted with WT BM before induction (BMT-KOs), eff ectively isolating Smad4 deletion to tissues outside the BM. Subsequent to gene deletion, the two models were monitored for weight gain as an indicator of health. Approximately 3 wk after induction, Smad4-defi cient mice began to lose weight and most were moribund 4 wk after induction (Fig. 1 a) . The BMT-KOs remained healthy for up to 7 wk after induction, as measured by weight gain, after which they slowly started to lose weight compared with WT controls (Fig. 1 b) . Histopathological examination of the liver, kidney, heart, lungs, esophagus, pancreas, and small intestines of Smad4 −/− mice did not reveal evidence of tissue damage or infl ammatory infi ltration, as has been previously reported in models defi cient in TGF-β signaling (unpublished data) (5-7). However, all Smad4 −/− animals examined (n = 6) demonstrated apparent pathological changes in the colonic mucosa ( Fig. 1 d) , characterized by dilated glands and an enlarged lamina propria surrounding the crypts of Lieberkuhns. Furthermore, the crypts were increased in size but reduced in number and were infi ltrated with macrophages. This fi nding had similarities with the phenotype seen in the small intestines of inducible MxCre/Bmpr1a-defi cient mice (19) . Surprisingly, colon histology of BMT-KO mice was normal 10 wk after induction (unpublished data), suggesting a mechanistic link between Smad4 deletion in the BM with the colon phenotype of Smad4 −/− mice. This result is especially intriguing in light of recent fi ndings by Kim et al., demonstrating a requirement for Smad4 in T cells in the maintenance of colon homeostasis (20) .
Peripheral blood (PB) cell counts revealed a substantial reduction in RBCs (Fig. 1 e) and hemoglobin levels (not depicted) in Smad4 −/− mice, whereas myeloid and lymphoid lineage distributions were normal (not depicted). Similarly, PB analysis revealed that BMT-KOs were also anemic, suggesting that Smad4 −/− BM-derived cells are not required to generate this particular phenotype (Fig. 1 e) . Feces from Smad4 −/− and BMT-KO mice stained positive for hemoglobin 3 wk after gene deletion (unpublished data), suggesting that Smad4 deletion in the colon resulted in intestinal hemorrhage. Interestingly, these symptoms are paralleled in patients suff ering from juvenile polyposis syndrome (17) .
Smad4 −/− HSCs possess normal differentiation capacity but impaired BM reconstitution
To determine the eff ect of Smad4 defi ciency on hematopoietic potential, we performed in vitro assays and BM transplantations. Colony and single-cell proliferation assays demonstrated that clonogenicity and proliferation of hematopoietic progenitors in vitro were unaff ected by Smad4 defi ciency despite the insensitivity of Smad4 −/− cells to TGF-β1 (Fig. S1 , a-d, available at http://www.jem.org/cgi/content/full/ jem.20060465/DC1). Furthermore, Smad4 −/− hematopoietic progenitors had normal homing potential (Fig. S2, a and b) , and recipients transplanted with Smad4 −/− BM were healthy and displayed normal PB cell counts and lineage distribution over the 16 wk they were monitored, suggesting that Smad4 is dispensable for the diff erentiation capacity of HSCs (Fig. 2 , a and b). Intriguingly, we did not observe any anemia nor changes in the colon of recipients engrafted with Smad4 −/− BM, suggesting that Smad4 deletion in both hematopoietic and colon cells is required for the observed disruption of homeostasis of the colon submucosa in Smad4 −/− steady-state mice. Earlier studies of TGF-β-null and inducible TβR-deficient mice resulted in a lethal multifocal infl ammatory disorder in primary mice and recipients of BM transplantations (5-7). Although this phenotype was mediated by T cells (6, 21) , the signaling mechanisms of the disease remain unknown. Importantly, recipients of Smad4 −/− donor BM showed no signs of this infl ammatory disease, suggesting that TGF-β-regulated T cell homeostasis is mediated through Smadindependent mechanisms. This conclusion is supported by a previous study in which Smad signaling was repressed through overexpression of the inhibitory Smad7 in HSCs without any observed infl ammatory phenotype (22) . Collectively, we conclude that canonical Smad signaling is dispensable for the infl ammatory phenotype earlier observed in transgenic mice with upstream disruptions of the TGF-β pathway. Instead, loss of Smad4 in both the hematopoietic system and in the colon leads to death of the mice because of a gastrointestinal disorder and intestinal hemorrhage with subsequent anemia.
Intriguingly, FACS analysis of long-term reconstituted recipients revealed a slight but signifi cant decrease in Smad4 −/− donor engraftment in the BM as compared with recipients of WT donor cells (89.32 ± 1.6% vs. 94.6 ± 1.5%, respectively; P < 0.03), with a corresponding increase of the endogenous Ly5.1 + fraction (Fig. 2 c) .
To confi rm that the reconstituting HSCs and progenitors were truly Smad4 −/− , we performed PCR analysis of CFU-GM colonies from recipient BM 16 wk after receiving BM transplants from six diff erent Smad4 −/− donors (Fig. 2 d) . Out of the 60 colonies analyzed, all were positive either for the null or the endogenous WT allele, whereas none were positive for fl oxed alleles, demonstrating highly effi cient MxCre-induced deletion of the Smad4 gene. Moreover, FACS analysis revealed that even though Smad4 −/− donor and recipient mice had normal fractions and absolute numbers of total HSC-enriched Lin − Sca1 + cKit + (LSK) cells as compared with controls (unpublished data), the proportion of donor-derived LSK cells was decreased in recipients receiving Smad4-defi cient BM compared with those receiving WT BM (82.7 ± 0.2% vs. 96.7 ± 0.05%, respectively; Fig. 2 , e and f). We followed this cell population through serial transplantations, passaging 2 × 10 6 BM cells to new lethally irradiated recipients. Intriguingly, FACS analysis of secondary recipients demonstrated that Smad4 −/− donor LSK cells were more quickly outcompeted by endogenous HSCs than were WT LSK cells (Fig. 2 f) , thus indicating HSC selfrenewal defects. Importantly, these analyses confi rmed that Smad4 −/− HSCs were capable of reconstituting the hematopoietic system but suggested that they were compromised in their ability to do so. In agreement with the impaired reconstitution capacity in noncompetitive assays, PB from recipients of Smad4 −/− BM analyzed 4 wk after transplantation had a 2.5-fold lower hematopoietic reconstitution as compared with recipients receiving WT BM (15.1 ± 3.72% vs. 34.8 ± 4.8%, respectively; P < 0.02). Moreover, the contribution of Smad4 −/− PB cells slightly decreased over time, reaching a level of 11.4 ± 3.5% at 16 wk after BM transplantation, as opposed to WT donor cells, which displayed a stable PB distribution over time (40.2 ± 8%; P < 0.01; Fig. 3, a and b) . Lineage distribution of the remaining Smad4 −/− BM was normal at all time points after transplantation up to and including 16 wk (Fig. 3 c) . Strikingly, Smad4 −/− cells demonstrated a 40-fold reduction in engraftment compared with WT controls upon secondary transplantation (Fig. 3 d) .
Furthermore, competitive repopulation units (CRUs) were quantifi ed by transplanting limiting doses of Smad4-defi cient or WT donor cells in competition with a set number (2 × 10 5 ) of normal cells to lethally irradiated recipients. The CRU 
BRIEF DEFINITIVE REPORT
frequency in the Smad4 −/− mice was estimated to be threefold lower as compared with control BM (Fig. 3 e) , further supporting the fi ndings of impaired reconstitution capacity and reduced numbers of phenotypically defi ned HSCs/progenitors.
Notably, FACS analyses of HSC-enriched populations demonstrated that cell-cycle status and apoptosis were unaff ected by Smad4 defi ciency (Fig. S3, a-d , available at http://www.jem.org/cgi/content/full/jem.20060465/DC1). However, in response to myeolablative stress in vivo, Smad4 −/− cells had a slight but signifi cant decrease in proliferative capacity compared with controls (Fig. S3, e and f) , suggesting that their capacity to proliferate may not be as robust as that of WT cells at times of acute demand for a replenished blood system.
To ask whether the Smad4 −/− phenotype was cell autonomous or dependent on the lack of Smad4 in the HSC niche, 2 × 10 6 uninduced Smad4 fl /fl or WT BM cells were transplanted to lethally irradiated mice. 10 wk after transplantation, Smad4 deletion was induced, producing chimeras with Smad4 −/− or WT HSCs in a normal HSC niche. Competitive transplantation experiments using BM cells harvested from these mice yielded an analogous phenotype as when performing competitive transplantation assays using Smad4 −/− donors averaging ‫%05ف‬ of the reconstitution levels of WT cells 7 wk after transplantation (Fig. 3 f) . Collectively, these experiments reveal a profound cell-autonomous defect in competitive repopulating capacity and self-renewal of Smad4 −/− HSCs. 
Molecular profi ling of Smad4 −/− LSK cells reveals down-regulation of Notch1 and c-myc
To gain insight into the eff ect of Smad4 deletion on HSC function, we performed gene expression profi ling using quantitative real-time PCR. LSK cells defi cient in Smad4 display reduced expression of the transcription factor and cell-cycle regulator c-myc, which was down-regulated 1.6-fold (P = 0.02; Table I ). A recent loss-of-function study manifested a dual role for c-myc in mouse HSC function. MxCre-induced c-myc defi ciency resulted in an expected decrease in proliferation of hematopoietic progenitors but also in an increase in HSC self-renewal, presumably because of defective migration out of the HSC niche (23) . However, earlier work by Satoh et al. demonstrated that ectopic expression of c-myc-induced self-renewal of HSCs in vitro (24) . In the same study, c-myc was shown to be transcriptionally induced by Notch signaling. Correspondingly, we also observed a signifi cant transcriptional down-regulation of the Notch1 receptor in Smad4-defi cient hematopoietic populations enriched for HSCs (Table I ). The Notch ligand Jagged1 is expressed on osteoblasts in the HSC niche in the BM and has been demonstrated to be an important regulator of HSC selfrenewal in vivo (25, 26) . The down-regulation of Notch1 would therefore be consistent with our observation of reduced self-renewal in vivo but unchanged in vitro proliferation of HSC-enriched populations.
Smad4 critically regulates adult HSC fate through the canonical Smad pathway and non-Smad regulatory circuits
In this paper, we demonstrate that Smad4 is critical for the regulation of HSC self-renewal in vivo without aff ecting the ratio of the diff erent hematopoietic lineages. Furthermore, it appears that the Smad4 −/− HSC phenotype is cell autonomous but dependent on extrinsic signaling from the in vivo microenvironment, because in vitro proliferation was normal in Smad4 −/− HSCs. Thus, our data suggest a positive role for Smad4 in HSCs in contrast to the documented growtharresting eff ect generated by the upstream TGF-β ligand. It is unlikely that this stimulatory eff ect is caused by the weak HSC growth-promoting signals documented for BMP4 on human cells in vitro, as BMP4 does not seem to have analogous eff ects in mouse BM (27) . In fact, recent work supports a negative role for Smad signaling on the whole in HSC selfrenewal, as interference of the pathway through oncoretroviral overexpression of the inhibitory Smad7 resulted in an in vivo expansion of HSCs (22) . This, together with the observations presented here, suggest a model for Smad signaling in the regulation of HSC self-renewal, where the positive role of Smad4 is caused by mechanisms outside the canonical Smad signaling pathway (Fig. 4) . This idea is supported by the observation that in vivo expansion of Smad7-overexpressing HSCs is dependent on Smad4 (22) .
An intriguing recent report demonstrates a previously unknown alternative pathway for TGF-β signaling in which TIF1γ competes with Smad4 to form complexes with Smad2 and 3. 
Fold change (KO/WT)
Cell-cycle regulators p15 (n = 2) nd p18 (n = 2) −1.17 ± 0.04
c-myc (n = 5) −1.6 ± 0.14** Transcription regulators Gata2 (n = 4) −1.31 ± 0.18
Notch1 (n = 5) −1.78 ± 0.18* Signaling molecules Lnk (n = 2) −1.12 ± 0.11
Results show the average fold difference in expression ± SEM. **, P = 0.02; and *, P = 0.03 as measured by paired t test. nd, not detectable.
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In an apparent balancing act, TGF-β-induced R-Smad-Smad4 complexes keep hematopoietic progenitors quiescent, whereas R-Smad-TIF1γ complexes direct human primitive hematopoietic cells toward erythroid diff erentiation (12) . Our data would support a model in which the absence of Smad4 tips the balance in favor of diff erentiation at the expense of self-renewing divisions. Additionally, emerging data suggest that other intracellular pathways directly aff ect Smad signal transduction. Such cross talk is well established between MAPK and Smad pathways, where it has been shown that the linker region of Smads can serve as a phosphorylation site for MAPKs, ultimately inhibiting Smad translocation to the nucleus (9). Furthermore, it has been demonstrated that β-catenin and Lef1/TCF, which are downstream mediators of the Wnt signaling cascade, can form a functional complex with Smad4 (11). Moreover, Notch and TGF-β signaling have been demonstrated to converge at the regulation of Hes1 expression (10) . These fi ndings are important in this context, because Wnt and Notch signaling stimulate proliferation of HSCs (25, 26, 28, 29) . In summary, we demonstrate that Smad4 is a critical regulator of HSC self-renewal in vivo without aff ecting lineage choice. Therefore, signaling pathways and other HSC regulators that require Smad4 to mediate their eff ects will be important topics for future studies of HSC function. BM transplantation assays. BM was harvested from 7-12-wk-old MxCre/Smad4 fl /fl and littermate control mice (Ly5.2) killed 7-10 d after the last poly I:C injection, and 2 × 10 6 BM cells were transplanted into the tail vein of lethally irradiated (9 cGy) C57BL/6 × B6SJL recipient mice (Ly5.1/Ly5.2). In the case of serial BM transplantations, 2 × 10 6 BM cells were passaged into new lethally irradiated recipients 8 wk after transplant. In the competitive repopulation assay, 2 × 10 5 Smad4 −/− or littermate control (WT) donor cells were transplanted into lethally irradiated Ly5.1/Ly5.2 recipients together with 2 × 10 5 competitor cells from B6SJL (Ly5.1) mice.
MATERIALS AND METHODS

Mice
In the case of competitive transplantation from the Smad4 fl /fl /WT chimeras, 2 × 10 6 BM cells from uninduced MxCre/Smad4 fl /fl were transplanted into WT C57BL/6 × B6SJL mice. 10 wk after transplantation, the mice were induced, and competitive transplantation was performed as described earlier in this section.
CRU assay was performed using four cell doses ranging between 5 × 10 3 and 10 5 BM cells per donor genotype, together with 2 × 10 5 normal competitor cells. PB was analyzed 12 wk after transplantation, and a cell dose was considered to contain at least one CRU if donor chimerism was >1% for both the myeloid and lymphoid lineages. The CRU frequency was calculated on the basis of negative recipients using L-calc software (StemCell Technologies Inc.).
FACS analyses.
The following fl uorochrome-conjugated antibodies were purchased from BD Biosciences: anti-B220, -CD3, -Gr1, -Mac1, -CD45.1, -CD45.2, -CD4, -CD8, -Ter119, -CD71, -Sca1, -Kit, and -CD34. Lineagepositive cells were labeled with unconjugated antibodies and Tri-colorc onjugated goat F(ab′) 2 anti-rat immunoglobulin G as a secondary antibody.
Quantitative RT-PCR. Gene-specifi c primers (Applied Biosystems) were used to analyze the expression of 20 genes of interest (Table I) , together with the housekeeping gene hypoxanthine guanine phosphoribosyl transferase (Hprt).
Online supplemental material. Fig. S1 shows that Smad4 −/− hematopoietic progenitors have normal in vitro proliferation and colony-forming capacity while being resistant to TGF-β-induced growth suppression. Fig.  S2 demonstrates that Smad4 is dispensable for homing of hematopoietic progenitors to the BM. Fig. S3 shows that Smad4 −/− hematopoietic progenitors have normal apoptosis and cell-cycle status while having a reduced stressinduced proliferative capacity. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20060465/DC1.
